Recent Market Snapshot on Global Post-traumatic Stress Disorder (PTSD) Therapeutics, 2015-2019

Global Post-traumatic Stress Disorder (PTSD) Therapeutics Market 2015-2019 is a new market research publication announced by Reportstack. PTSD is a psychological condition that develops after a person is exposed to any traumatic event, and it drains a person emotionally. According to the DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association (APA), PTSD is classified under anxiety disorders. PTSD can occur in individuals of any age, irrespective of the gender; its symptoms can develop immediately after a traumatic event or during the course of time. Its symptoms normally include re-experience of the traumatic event, avoidance of the incidents, and abnormal mood swings. Treatments for PTSD include psychological counselling, which help in identifying the cause of the condition and providing counselling to come out of the situation. Medications present in the market help in reducing the symptoms during the course of the treatment.

The analysts forecast that the global PTSD therapeutics market to grow at a CAGR of 1.09% over the period 2014-2019.

Complete report with TOC available @ Global Post-traumatic Stress Disorder (PTSD) Therapeutics Market 2015-2019.

Covered in this Report
This report covers the present scenario and the growth prospects of the global PTSD therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various generic, off-label, and branded therapies used for the treatment of PTSD. This report includes the segmentation of the market based on geography.

Key Regions
• Americas
• EMEA       

Key Vendors
• GlaxoSmithKline
• Pfizer
• Otsuka Pharmaceutical

Other Prominent Vendors
• Azevan Pharmaceuticals
• Baylor Research Institute
• Eli Lilly
• Forest Laboratories
• H. Lundbeck
• Humanetics Pharmaceuticals
• Marinus Pharmaceuticals
• Nanotherapeutics
• Neurocrine Biosciences
• Novartis Pharmaceuticals
• Synchroneuron
• Tonix Pharmaceuticals

Market Driver
• Growing Number of Accidents and Violence Worldwide
• For a full, detailed list, view our report

Market Challenge
• Unavailability of Standard Diagnostic Methods
• For a full, detailed list, view our report

Market Trend
• Rise in Public Awareness
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research